This was the first study which investigated (a) the role of Visfatin in sepsis-induced intestinal injury, (b) the effect of Visfatin on sepsis-induced intestinal pathological injury, as well as the intestinal cell apoptosis and inflammation, and (c) the potential signaling pathways that were involved in the functions of Visfatin. The gene discussed is NAMPT; the disease is Sepsis.